MM

Monique Moreau

AS Aventis Pasteur S.A.: 3 patents #2 of 26Top 8%
PS Pasteur Mérieux Sérums Et Vaccins S.A.: 3 patents #2 of 69Top 3%
SS Sanofi Pasteur Sa: 3 patents #14 of 76Top 20%
BS Biosynth S.R.L.: 1 patents #2 of 7Top 30%
SP Sanofi Pasteur: 1 patents #111 of 238Top 50%
Overall (All Time): #509,820 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10137145 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Noelle Mistretta, Genevieve Renauld-Mongenie, Bachra Rokbi 2018-11-27
9669052 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Noelle Mistretta, Genevieve Renauld-Mongenie, Bachra Rokbi 2017-06-06
9132181 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Noelle Mistretta, Genevieve Renauld-Mongenie, Bachra Rokbi 2015-09-15
7812006 Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide Noelle Mistretta, Emilie Danve 2010-10-12
7507718 Polymyxin B analogs for LPS detoxification Massimo Porro, Massimo Velucchi, Alessandro Rustici, Noelle Mistretta, Tino Krell 2009-03-24
7235242 IgA1 protease fragment as carrier peptides Mark Achtman 2007-06-26
6596861 Method for the reductive amination of polysaccharides 2003-07-22
6472506 Polysaccharide-peptide-conjugates Noelle Mistretta 2002-10-29
6045805 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent 2000-04-04
6007818 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent 1999-12-28